Author | Kevin E. Noonan

Kevin E. Noonan, Ph.D, is a Partner with McDonnell Boehnen Hulbert & Berghoff LLP. He can be reached at


Global Biologic Drug Development and the TTP


Kevin E. Noonan asks, what do the biosimilars provisions of the Trans-Pacific Partnership portend for global biologic drug development?